A Phase 1b safety study of SER-287, a spore-based microbiome therapeutic, for active mild to moderate ulcerative colitis

出版年份 2020 全文链接

标题

作者

关键词

Inflammatory bowel disease, gastrointestinal microbiome, microbe-associated metabolites, microbiome therapeutics

出版物

Volume -, Issue -, Pages -

出版商

Elsevier BV

发表日期

2020-08-04

DOI

10.1053/j.gastro.2020.07.048

联系作者

Discuss science. Find collaborators. Network.

Join a conversation

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now